首页 > 市场调查报告书 > 医疗设备

生技设备 3D列印

市场调查报告书

商品编码

1609861

Componen（3D 生物列印机、支架、生物材料）、应用（研究、临床）、最终用户（医院、研究组织和学术机构、生物製药公司）和地区的日本 3D 生物列印市场报告 2025-2033

Japan 3D Bioprinting Market Report by Component (3D Bioprinters, Scaffolds, Biomaterials), Application (Research, Clinical), End User (Hospitals, Research Organization and Academic Institutes, Biopharmaceuticals Companies), and Region 2025-2033

出版日期: 2024年12月05日 | 出版商:

IMARC | 英文 122 Pages | 商品交期: 5-7个工作天内

价格

简介目录

2024年日本3D生物列印IMARC Group规模达8,290万美元。老年人口对器官移植的需求不断增加，以及获得医疗技术的便利性，主要推动了市场的成长。

三维 (3D) 生物列印是一种积层製造技术，专为精确製造解剖组织而开发。此方法涵盖各种沉积和组装工艺，包括直接写入和雷射写入、微冲压、光刻、立体光刻、电子印刷和喷墨沉积。除此之外，它还依靠基于细胞的生物墨水的逐层组装来构建3D组织和器官结构，这些生物墨水是使用活细胞、生物材料和活性生物分子配製而成的。透过沉积多层生物材料，3D 生物列印可以创建复杂的身体结构，如骨骼、皮肤、软骨、血管移植物、气管夹板和心臟组织。因此，它在日本各地的医院、研究机构、学术机构和生物製药公司中得到了广泛的应用。

日本3D生物列印市场趋势：

在日本市场背景下，越来越重视减少动物试验是对该产业产生正面影响的重要因素。此外，对3D生物列印的需求不断增长，特别是在更容易患各种慢性疾病的老年族群中，正在培育良好的市场前景，从而成为另一个重要的成长诱导因素。除此之外，晶片器官系统的开发等技术进步也正在推动市场成长。此外，全球对再生医学、癌症治疗和干细胞解决方案的需求不断增长，也促进了市场的扩张。除此之外，日本的医疗保健产业越来越多地采用3D生物列印，与其他产业相比，其干扰程度相对较低，为市场成长提供了大力支持。此外，知名製造商非常重视旨在推出生物印刷纸巾的研发（R＆D）活动，这对区域市场产生了正面影响。这项努力旨在降低与新创新相关的成本并简化药物发现流程，进一步推动日本国内的进步。所有上述因素预计将在预测期内促进市场成长。

日本3D生物列印市场细分：

组件见解：

3D生物列印机
注射器/挤出生物列印
喷墨生物列印
磁浮生物列印
雷射辅助生物列印
其他的
鹰架
生物材料
活细胞
水凝胶
细胞外基质
其他的

应用见解：

研究
药物研究
再生医学
3D 细胞培养
临床
皮肤
骨骼和软骨
血管
其他的

最终使用者见解：

医院
研究机构及学术机构
生物製药公司

竞争格局：

市场研究报告也对竞争格局进行了全面分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。

本报告回答的关键问题：

日本 3D 生物列印市场迄今表现如何，未来几年又将如何表现？
COVID-19 对日本 3D 生物列印市场有何影响？
日本3D生物列印市场依组件划分是怎样的？
日本3D生物列印市场在应用方面的细分情况如何？
日本 3D 生物列印市场在最终用户方面的细分情况如何？
日本3D生物列印市场价值链的各个阶段是什么？
日本3D生物列印的关键驱动因素与挑战是什么？
日本3D生物列印市场的结构如何？
日本3D生物列印市场的竞争程度如何？

本报告回答的关键问题：

日本 3D 生物列印市场迄今表现如何，未来几年又将如何表现？
COVID-19 对日本 3D 生物列印市场有何影响？
日本3D生物列印市场依组件划分是怎样的？
日本3D生物列印市场在应用方面的细分情况如何？
日本 3D 生物列印市场在最终用户方面的细分情况如何？
日本3D生物列印市场价值链的各个阶段是什么？
日本3D生物列印的关键驱动因素与挑战是什么？
日本3D生物列印市场的结构如何？
日本3D生物列印市场的竞争程度如何？

3D生物列印机
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场区隔
  - 注射器/挤出生物列印
  - 喷墨生物列印
  - 磁浮生物列印
  - 雷射辅助生物列印
  - 其他的
- 市场预测（2025-2033）
鹰架
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
生物材料
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场区隔
  - 活细胞
  - 水凝胶
  - 细胞外基质
  - 其他的
- 市场预测（2025-2033）

第 7 章：日本 3D 生物列印市场 - 细分：按应用分类

研究
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场区隔
  - 药物研究
  - 再生医学
  - 3D 细胞培养
- 市场预测（2025-2033）
临床
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场区隔
  - 皮肤
  - 骨骼和软骨
  - 血管
  - 其他的
- 市场预测（2025-2033）

第 8 章：日本 3D 生物列印市场 - 细分：按最终用户划分

医院
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
研究机构及学术机构
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）
生物製药公司
- 概述
- 历史与当前市场趋势（2019-2024）
- 市场预测（2025-2033）

第 8 章：日本 3D 生物列印市场 - 竞争格局

概述
市场结构
市场参与者定位
最佳制胜策略
竞争仪表板
公司评估象限

第 9 章：关键参与者简介

Company A

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company B

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company C

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company D

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company E

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

第 10 章：日本 3D 生物列印市场 - 产业分析

驱动因素、限制因素和机会
- 概述
- 司机
- 限制
- 机会
波特五力分析
- 概述
- 买家的议价能力
- 供应商的议价能力
- 竞争程度
- 新进入者的威胁
- 替代品的威胁
价值链分析

第 11 章：附录

简介目录

Product Code: SR112024A18261

Japan 3D bioprinting market size reached USD 82.9 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 316.7 Million by 2033, exhibiting a growth rate (CAGR) of 16.1% during 2025-2033. The elevating need for organ transplantation among the geriatric population, along with the easy access to medical technologies, is primarily driving the market growth.

Three-dimensional (3D) bioprinting is an additive manufacturing technique developed for the precise fabrication of anatomical tissues. This method encompasses various deposition and assembly processes, including direct and laser writing, microstamping, photolithography, stereolithography, electro-printing, and inkjet deposition. In addition to this, it relies on the layer-by-layer assembly of cell-based bio-inks, which are formulated using living cells, biomaterials, and active biomolecules, to construct 3D tissue and organ structures. By depositing multiple layers of biomaterials, 3D bioprinting can create complex bodily structures such as bones, skin, cartilage, vascular grafts, tracheal splints, and heart tissues. Consequently, it finds extensive applications in hospitals, research institutions, academic establishments, and biopharmaceutical companies across Japan.

Japan 3D Bioprinting Market Trends:

In the context of the Japan market, the increasing emphasis on reducing animal testing is a significant factor positively influencing the industry. Additionally, the rising demand for 3D bioprinting, particularly among the elderly population who are more susceptible to various chronic illnesses, is fostering a favorable market outlook, thereby acting as another significant growth-inducing factor. Besides this, technological advancements such as the development of organ-on-a-chip systems are also driving market growth. Furthermore, the surging global demand for regenerative medicines, cancer therapeutics, and stem cell solutions is contributing to the expansion of the market. Apart from this, the healthcare sector in Japan is increasingly adopting 3D bioprinting, and its relatively lower disruption level compared to other industries is providing substantial support to market growth. Moreover, prominent manufacturers are placing a strong focus on research and development (R&D) activities aimed at introducing bio printed tissues, which is positively influencing the regional market. This effort aims to reduce the cost associated with new innovations and streamline the drug discovery process, further propelling advancement within Japan. All these above mentioned factors are expected to catalyze the market growth over the forecasted period.

Japan 3D Bioprinting Market Segmentation:

Component Insights:

3D Bioprinters
Syringe/Extrusion Bioprinting
Inkjet Bioprinting
Magnetic Levitation Bioprinting
Laser-assisted Bioprinting
Others
Scaffolds
Biomaterials
Living Cells
Hydrogels
Extracellular Matrices
Others

Application Insights:

Research
Drug Research
Regenerative Medicine
3D Cell Culture
Clinical
Skin
Bone and Cartilage
Blood Vessels
Others

End User Insights:

Hospitals
Research Organization and Academic Institutes
Biopharmaceuticals Companies

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan 3D bioprinting market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan 3D bioprinting market?
What is the breakup of the Japan 3D bioprinting market on the basis of component?
What is the breakup of the Japan 3D bioprinting market on the basis of application?
What is the breakup of the Japan 3D bioprinting market on the basis of end user?
What are the various stages in the value chain of the Japan 3D bioprinting market?
What are the key driving factors and challenges in the Japan 3D bioprinting?
What is the structure of the Japan 3D bioprinting market and who are the key players?
What is the degree of competition in the Japan 3D Bioprinting market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan 3D Bioprinting Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan 3D Bioprinting Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan 3D Bioprinting Market - Breakup by Component

6.1 3D Bioprinters
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Segmentation
  - 6.1.3.1 Syringe/Extrusion Bioprinting
  - 6.1.3.2 Inkjet Bioprinting
  - 6.1.3.3 Magnetic Levitation Bioprinting
  - 6.1.3.4 Laser-assisted Bioprinting
  - 6.1.3.5 Others
- 6.1.4 Market Forecast (2025-2033)
6.2 Scaffolds
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
6.3 Biomaterials
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Segmentation
  - 6.3.3.1 Living Cells
  - 6.3.3.2 Hydrogels
  - 6.3.3.3 Extracellular Matrices
  - 6.3.3.4 Others
- 6.3.4 Market Forecast (2025-2033)

7 Japan 3D Bioprinting Market - Breakup by Application

7.1 Research
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Segmentation
  - 7.1.3.1 Drug Research
  - 7.1.3.2 Regenerative Medicine
  - 7.1.3.3 3D Cell Culture
- 7.1.4 Market Forecast (2025-2033)
7.2 Clinical
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Segmentation
  - 7.2.3.1 Skin
  - 7.2.3.2 Bone and Cartilage
  - 7.2.3.3 Blood Vessels
  - 7.2.3.4 Others
- 7.2.4 Market Forecast (2025-2033)

8 Japan 3D Bioprinting Market - Breakup by End User

8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Research Organization and Academic Institutes
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Biopharmaceuticals Companies
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)

8 Japan 3D Bioprinting Market - Competitive Landscape

8.1 Overview
8.2 Market Structure
8.3 Market Player Positioning
8.4 Top Winning Strategies
8.5 Competitive Dashboard
8.6 Company Evaluation Quadrant

9 Profiles of Key Players

9.1 Company A
- 9.1.1 Business Overview
- 9.1.2 Product Portfolio
- 9.1.3 Business Strategies
- 9.1.4 SWOT Analysis
- 9.1.5 Major News and Events
9.2 Company B
- 9.2.1 Business Overview
- 9.2.2 Product Portfolio
- 9.2.3 Business Strategies
- 9.2.4 SWOT Analysis
- 9.2.5 Major News and Events
9.3 Company C
- 9.3.1 Business Overview
- 9.3.2 Product Portfolio
- 9.3.3 Business Strategies
- 9.3.4 SWOT Analysis
- 9.3.5 Major News and Events
9.4 Company D
- 9.4.1 Business Overview
- 9.4.2 Product Portfolio
- 9.4.3 Business Strategies
- 9.4.4 SWOT Analysis
- 9.4.5 Major News and Events
9.5 Company E
- 9.5.1 Business Overview
- 9.5.2 Product Portfolio
- 9.5.3 Business Strategies
- 9.5.4 SWOT Analysis
- 9.5.5 Major News and Events

10 Japan 3D Bioprinting Market - Industry Analysis

10.1 Drivers, Restraints, and Opportunities
- 10.1.1 Overview
- 10.1.2 Drivers
- 10.1.3 Restraints
- 10.1.4 Opportunities
10.2 Porters Five Forces Analysis
- 10.2.1 Overview
- 10.2.2 Bargaining Power of Buyers
- 10.2.3 Bargaining Power of Suppliers
- 10.2.4 Degree of Competition
- 10.2.5 Threat of New Entrants
- 10.2.6 Threat of Substitutes
10.3 Value Chain Analysis